Back to search

United States· US:84148-027_4f8ae723-9e43-d056-e063-6394a90a83f2

Chanvida Broad Spectrum BB Cream

A medicinal product containing retinol; dipeptide diaminobutyroyl benzylamide diacetate; acetyl hexapeptide-8; acetyl tetrapeptide-5; zinc oxide; glycyrrhiza glabra (licorice) root; sodium hyaluronate; alpha-tocopherol acetate; 3-o-ethyl ascorbic acid; niacinamide, registered in United States by Guangzhou Ariel Biotech Co., Ltd..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedChanvida Broad Spectrum BB CreamATC—REGISTER NO.US:84148-027_4f8ae723…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
RETINOL; DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE; ACETYL HEXAPEPTIDE-8; ACETYL TETRAPEPTIDE-5; ZINC OXIDE; GLYCYRRHIZA GLABRA (LICORICE) ROOT; SODIUM HYALURONATE; ALPHA-TOCOPHEROL ACETATE; 3-O-ETHYL ASCORBIC ACID; NIACINAMIDE
Manufacturer
Guangzhou Ariel Biotech Co., Ltd.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    84148-027-01
  • ndc11
    8414802701
    50 g in 1 BOTTLE (84148-027-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8547a7be-3dc9-44d0-bd8e-6d98830a120d
GET /v1/drugs/8547a7be-3dc9-44d0-bd8e-6d98830a120d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "CUTANEOUS",
  "source": "ndc",
  "strength": ".01; .001; .001; .001; 9.7; .01; .11; .5; 1; 2.5",
  "substance": "RETINOL; DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE; ACETYL HEXAPEPTIDE-8; ACETYL TETRAPEPTIDE-5; ZINC OXIDE; GLYCYRRHIZA GLABRA (LICORICE) ROOT; SODIUM HYALURONATE; ALPHA-TOCOPHEROL ACETATE; 3-O-ETHYL ASCORBIC ACID; NIACINAMIDE",
  "productndc": "84148-027",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about retinol; dipeptide diaminobutyroyl benzylamide diacetate; acetyl hexapeptide-8; acetyl tetrapeptide-5; zinc oxide; glycyrrhiza glabra (licorice) root; sodium hyaluronate; alpha-tocopherol acetate; 3-o-ethyl ascorbic acid; niacinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.